Navigation Links
Cardiovascular Meds May Be Beneficial in Alzheimer's Disease, According to MedPredict Report
Date:5/29/2008

SCOTTSDALE, Ariz., May 29 /PRNewswire/ -- MedPredict has published a new report designed to provide critical strategic insight for pharma and biotech companies with a stake in the market for diagnostics and treatments in this disease area. The report, entitled "Thought Leader Insight & Analysis: Alzheimer's Disease," is based on in-depth interviews conducted with a panel of physician thought leaders actively involved in ongoing research.

"There is some real progress being made in development of diagnostics and treatments for Alzheimer's disease," said Dr. Jeffrey Berk, the primary author of this report. "We expect demand for diagnostics is going to skyrocket in concert with approvals of agents that alter the course of the disease. There are three objectives for an Alzheimer's diagnostic: to diagnose the disease, to track changes in the course of the disease, and to confirm the effect of drugs. Our panelists are most excited about amyloid imaging using a tracer chemical called PIB."

MedPredict's report discusses the emerging data associating cardiovascular drugs with slowing of disease progression and symptomatic benefit in Alzheimer's disease. According to Dr. Berk, "There is intriguing new data suggesting some antihypertensives might have a role in significantly reducing Alzheimer's dementia." Other disease modification approaches discussed by the panel include passive and active immunotherapies, gamma-secretase inhibitors and modulators, beta-secretase inhibitors, insulin related mechanisms, and others.

MedPredict's panel addresses other therapies in development for symptomatic benefit in Alzheimer's, aimed at improving cognition and physical symptoms, including cholinesterase inhibitors, NMDA antagonists, dimebolin, alpha-7 nicotinic acetylcholine agonists, and others.

Companies mentioned in this report: GE Healthcare, Avid, Bayer Schering, Siemens, C2N Diagnostics, Satoris, Novartis, Forest, Merz, Lundbeck, Daiichi Sankyo, Medivation, Abbott, AstraZeneca, Targacept, Roche, Memory, EnVivo, Wyeth, Epix, GlaxoSmithKline, Merck, Takeda, Sanofi-Aventis, Bristol Myers Squibb, Boehringer Ingelheim, Baxter, Lilly, Intellect Neurosciences, Elan, Myriad, AC Immune, Genentech, Affiris, TransTec, Pfizer, TorreyPines, Transition Therapeutics, Neurochem.

The full report can be purchased by contacting MedPredict.

About MedPredict

MedPredict (http://www.medpredict.com) maintains a proprietary database of over 1,000 global physician thought leaders, including 40+ specialties in 30+ therapeutic categories. Based on primary interviews with these thought leaders, MedPredict publishes periodic reports in each category to keep clients up-to-date on emerging trends and competitive activity. The reports include thought leader reactions to recent publications and medical conferences, as well as clinical, regulatory and marketing activity.


'/>"/>
SOURCE MedPredict
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Study shows pine bark naturally reduces cardiovascular risk factors in diabetics
2. Study Shows Pine Bark Naturally Reduces Cardiovascular Risk Factors in Diabetics
3. American Academy of Pediatrics/American Heart Association Clarification of Statement on Cardiovascular Evaluation and Monitoring of Children and Adolescents With Heart Disease Receiving Medications for ADHD
4. Excess Drinking Boosts Cardiovascular Disease Risk
5. Cardica, Intuitive Surgical, MAQUET Cardiovascular and Transonic to Host Innovations in Revascularization Symposium
6. Concern From Doctors Regarding the Cardiovascular Safety of GlaxoSmithKlines Avandia Increases Nine-Fold Following Publication of Meta-Analysis
7. Spirit of the Heart: Preventing Cardiovascular Disease: A Community Call to Action
8. MAQUET Cardiovascular Launches HEARTSTRING III Proximal Seal System for Coronary Artery Bypass Graft Surgery
9. Terumo Cardiovascular Systems Responds to Allegations of Patent Infringement
10. Sexual dissatisfaction in postmenopausal women not linked to cardiovascular disease
11. Mary Cheney Joins the Cheney Cardiovascular Institute Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Michigan (PRWEB) , ... June 26, 2016 , ... On ... as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle ... honor of the city’s history as home to some of the world’s leading providers ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... On Friday, ... presented a Bronze Wellness at Work award to iHire in recognition of their exemplary ... part of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell ... pain and the benefits of holistic treatments, Serenity Recovery Center of Marne, ... Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... HILL, N.C. , June 24, 2016 /PRNewswire/ ... healthcare decisions and regulators/payers have placed more emphasis ... new environment, patient support programs in the pharmaceutical ... for patients, medications. Consequently, pharmaceutical companies are focusing ... ensure they are providing products and services that ...
(Date:6/24/2016)... FRANCISCO, Calif. , June 24, 2016 /PRNewswire/ ... ), a biopharmaceutical company developing novel therapeutics for ... unmet needs, today announced the closing of its ... of common stock, at the public offering price ... in the offering were offered by GBT. GBT ...
(Date:6/24/2016)... , June 24, 2016 ... Markets has announced the addition of the " ... offering. This ... and provides an updated review, including its applications in ... the total market, which includes three main industries: pharmaceutical ...
Breaking Medicine Technology: